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Abstract
Introduction: Delayed patient admission to the intensive care unit (ICU) due to lack of bed availability is a
common problem, but the effect on patient outcome is not fully known.
Methods: A retrospective study was performed using departmental computerised records to determine the effect
of delayed ICU admission and temporary management within the operating theatre suite on patient outcome.
Emergency surgical and medical patients admitted to the ICU (2003 to 2007) were divided into delay (more than
three hours from referral to admission) and no-delay (three or fewer hours from referral to admission) groups. Our
primary outcome measure was length of ICU stay. Secondary outcome measures were mortality rates and duration
of organ support.
Results: A total of 1,609 eligible patients were included and 149 (9.3%) had a delayed admission. The delay and
no-delay groups had similar baseline characteristics. Median ICU stay was 5.1 days (delay) and 4.5 days (no-delay)
(P = 0.55) and ICU mortality was 26.8% (delay) and 24.2% (no-delay) (P = 0.47). Following adjustment for
demographic and baseline characteristics there was no difference in either length of ICU stay or mortality rates
between groups. ICU admission delay was associated with both an increased requirement for advanced respiratory
support (92.3% delay vs. 76.4% no-delay, P <0.01) and a longer time spent ventilated (median four days delay vs.
three days no-delay, P = 0.04).
Conclusions: No significant difference in length of ICU stay or mortality rate was demonstrated between the delay
and no-delay cohorts. Patients within the delay group had a significantly greater requirement for advanced
respiratory support and spent a longer time ventilated.
Introduction
Demand for critical care services is increasing worldwide
[1] and there are large variations in Intensive Care Unit
(ICU) bed provision between countries. In the United
Kingdom (UK) this figure remains low and compares
unfavourably with other nations [2] despite recent
increases in absolute bed numbers [3]. This was high-
lighted by the problems faced during the recent winter
flu surge in which operating theatres and recovery areas
were adapted in order to cope with the extra demand
for ICU beds [4].
The incidence of severe sepsis, the most common
cause for general ICU admission, is increasing [5,6] with
forecasts suggesting that this will continue, due to an
ageing population [7] and that this will increase pressure
on pre-existing ICU beds. Bed availability is further hin-
dered by the increasing number of ICU discharges that
are delayed due to a shortage of general ward beds [3].
These factors contribute to a situation whereby an ICU
bed may not be immediately available when a patient
requires admission. In one UK study, 14% of ICU refer-
rals were refused due to a lack of ICU beds [8] with
* Correspondence: anthony.gordon@imperial.ac.uk
1Section of Anaesthetics, Pain Medicine and Intensive Care, Imperial College
London, Chelsea and Westminster Hospital Campus, 369 Fulham Road,
London SW10 9NH, UK
Full list of author information is available at the end of the article
O’Callaghan et al. Critical Care 2012, 16:R173
http://ccforum.com/content/16/5/R173
© 2012 O’Callaghan et al.; licensee BioMed Central Ltd. This is an open access article distributed under the terms of the Creative
Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
65% of UK intensive care specialists reporting ICU
admissions to be limited by bed availability [9].
The net result of these processes is that difficult deci-
sions about patient admission and transfer will become
increasingly common. The process of transfer for non-
clinical reasons (that is, for comparable care rather than
for specialist care) can often leave the clinician facing a
dilemma [10]: should they transfer the new potentially
unstable patient to an alternative centre or relocate a
more physiologically stable existing patient? Transfer
itself can be associated with adverse events and deteriora-
tion in patient physiology [11,12], with inter-hospital
transfer associated with a worse outcome than remaining
within an institution [13]. In the UK much of the data
collection surrounding transfers is inadequate [14] so
that accurately quantifying risk/benefit ratio is difficult.
The alternative to inter-hospital transfer is to manage
the new patient on site until an ICU bed becomes avail-
able. This is the policy employed within Charing Cross
Hospital where the operating theatre suite is often used
to provide a suitably monitored environment in which to
manage the patient. However, this policy of “boarding” a
patient rather than transferring out can result in a
delayed ICU admission. There is currently no UK-based
study and a general paucity of evidence examining the
impact of both this specific holding strategy or of a
delayed ICU admission on patient outcome.
We, therefore, examined the effect of a delayed admis-
sion to ICU and of this specific management strategy of
“boarding” patients in the operating theatre suite on out-
comes as determined by length of ICU stay, mortality
rates and duration of organ support.
Materials and methods
Study
Ethics committee approval was waived for this study as
it involved retrospective analysis of anonymous, routi-
nely collected, group data.
Departmental computerised patient records were ana-
lysed to identify eligible patients admitted to the ICU
between 1 January 2003 and 31 December 2007. During
this period, Charing Cross Hospital ran between 475 and
582 beds with a 12-bed ICU admitting adult medical and
surgical patients, including neurosciences. There were four
full-time intensive care specialists in 2003, this increased
to five in 2004 but remained constant for the remainder of
the study period. The hospital has an Emergency Depart-
ment but no paediatric, cardiothoracic surgery, or obste-
trics and gynaecology services. The hospital underwent a
merger at the end of 2007 and the ICU expanded at this
time; hence, this was used as the study endpoint.
A delayed admission was defined according to our
regional critical care network guidelines as taking
greater than three hours from the point of acceptance
by the critical care team to patient arrival on the ICU.
Time spent for patient investigation and/or treatment
was not classified as delay. Readmissions, elective surgi-
cal admissions and inter-hospital transfers into the ICU
were excluded. Patients readmitted to the ICU during
the same hospital admission were classed as readmis-
sions and those receiving a planned surgical procedure
(even if the ICU admission was not planned) were
classed as elective surgical admissions.
Data collection and analysis
Demographic data, including age, sex, diagnosis, admis-
sion category (medical or surgical), Acute Physiology
and Chronic Health Evaluation (APACHE) II score [15]
and source of admission, were collected. The primary
reason for ICU admission, as well as physiological and
laboratory data for the first 24 hours after ICU referral,
were also recorded.
Recorded outcome variables for all patients were
length of ICU stay, and ICU and hospital mortality. The
UK critical care minimum dataset [16] was introduced
on 1 April 2006 and daily organ support data were col-
lected from this date onwards. The definitions of organ
support are listed in Table 1.
Patient data were extracted from the hospital database
and analysed using Microsoft Excel 2010 (Microsoft,
Redmond, Washington USA) and Statistical Package for
the Social Sciences version 19 (IBM, Armonk, New York,
USA). Continuous variables were analysed using the Stu-
dent’s t-test or Mann-Whitney U test as appropriate.
Categorical data were analysed using a Chi-squared test.
Multivariate regression models were used to adjust for
baseline characteristics (including age, sex, APACHE II
score, delay admission category and other variables that
were significantly different between the two groups)
when examining the effect of delayed admission on
length of ICU stay and ICU mortality. A P-value of less
than 0.05 was considered statistically significant.
Results
Between January 2003 and December 2007, 2,652
patients were admitted to Charing Cross Hospital ICU.
Of these, 1,609 met the inclusion criteria (Figure 1) and
149 patients (9.3%) had a delayed admission. The annual
rates of delayed admission were 4.9% (13/268) in 2003,
10.9% (33/302) in 2004, 14.1% (48/341) in 2005, 5.2%
(18/349) in 2006 and 10.1% (37/349) in 2007. For all
patients, ICU survival status and length of ICU stay was
known but hospital survival status was not recorded for
16 patients. There were 598 patients admitted to ICU
from 1 April 2006 to 31 December 2007 who also had
daily organ support data collected.
Demographic data were similar between the delayed
and non-delayed groups (Table 2), other than a trend
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towards lower age within the delay group (55 ± 17
years) compared to the no-delay group (57 ± 19 years, P
= 0.07). The median duration of delay was 6 hours (IQR
4.5 to 10 hours). Within the delay group 28 patients
(18.8%) were admitted directly from the ward, 11 (7.4%)
from the Emergency Department (ED) and 110 (73.8%)
from the theatre suite. Only 32 patients (21.5%) in the
delay group had undergone an operative intervention,
Table 1 Organ support categories as defined by critical care minimum data set, January 2006
Basic respiratory support More than 50% oxygen delivered by face mask
Close observation due to potential for acute deterioration
Physiotherapy or suction to clear secretions at least two hourly
Patients recently extubated after a prolonged period of intubation and mechanical ventilation
Mask CPAP or non-invasive ventilation
ETT but no support
Advanced respiratory support Invasive mechanical ventilatory support
BiPAP or CPAP applied via a tracheal tube
Extracorporeal respiratory support
Basic cardiovascular support Treatment of circulatory instability due to hypovolaemia
Use of a CVP line
Use of an arterial line
Single intravenous vasoactive drug
Intravenous drugs to control cardiac arrhythmias
Non-invasive measurement of cardiac output
Advanced cardiovascular support Multiple intravenous vasoactive and/or rhythm controlling drugs
Patients resuscitated after cardiac arrest where intensive therapy is considered clinically appropriate
Observation of cardiac output and derived indices
Intra aortic balloon pumping
Insertion of a temporary cardiac pacemaker
Placement of a gastrointestinal tonometer
Renal support Acute renal replacement therapy
CPAP, continuous positive airway pressure; CVP, central venous pressure; ETT. endo-tracheal tube; BiPAP, bi-level positive airway pressure
Figure 1 Patient flow.
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which was significantly less than the no-delay group
(30.5%, P = 0.02). The other 78 patients admitted to
ICU from the theatre suite were transferred there from
elsewhere in the hospital for continued management
pending ICU admission. The delay group had a signifi-
cantly higher percentage of patients with respiratory fail-
ure as a cause for admission (25.5% vs. 15.6%, P < 0.01)
than the no-delay group and a lower partial pressure of
oxygen in the blood (PaO2):fraction of inspired oxygen
(FiO2) ratio (25.8 ± 15.1 vs. 29.6 ± 18.0, P = 0.02) and a
lower Glasgow Coma Scale (GCS) (6, IQR 3 to 15 vs.
10, IQR 3 to 15, P = 0.03) in the first 24 hours after
ICU referral.
There was no significant difference in length of ICU
stay between the delay group (median 5.1 days, IQR 1.9
to 9.8) and no-delay group (median 4.5 days, IQR = 1.8
to 9.4, P = 0.55) (Figure 2). There was no significant dif-
ference in ICU mortality (delay = 26.8% (40/149) vs. no-
delay = 24.2% (353/1,460); P = 0.47) or hospital mortality
(delay = 36.2% (54/149); no-delay = 32.8% (479/1,460);
P = 0.44) between the groups (Table 2).
We performed multivariate regression analysis to
adjust for any imbalances at baseline between the delay
and no-delay groups. Using linear regression analysis,
delayed admission was not associated with length of ICU
stay (b 0.48, 95% CI -1.5 to 2.46, P = 0.64, Table 3). Simi-
larly, on binary logistic regression analysis, there was no
association between ICU mortality (OR 1.27, 95% CI 0.81
to 2.0, P = 0.29,Table 4) and delayed admission. Increas-
ing age, male sex and operative intervention were asso-
ciated with increased ICU stay (Table 3). Increasing
APACHE II score was associated with significantly higher
ICU mortality (Table 4).
There was no association between length of delay in
hours and mortality. Within the delay group, the odds
ratio for ICU mortality was 0.97 for each hour delay (95%
CI 0.89 to 1.05, P = 0.41). We further tested if the longest
delays affected outcome (those patients in the highest
Table 2 Demographic and baseline characteristics for delay and no-delay groups
DelayN = 149 No-DelayN = 1,460 P - value
Age 55 ± 17 57 ± 19 0.07
Male sex 94 (63.1) 902 (61.8) 0.64
Referring specialty:
Medical 86 (57.3) 833 (57.1) 0.88
Surgical 63 (42.3) 627 (42.9)
APACHE II score 20 (15 to 26) 20 (1 to 26) 0.99
Comorbidities:
COPD/Asthma 17 (11.4) 142 (9.7) 0.51
Ischaemic heart disease 15 (10.1) 148 (10.1) 0.98
End stage renal failure 5 (3.4) 35 (2.4) 0.48
Metastatic cancer 7 (4.7) 47 (3.2) 0.34
Acquired immunosuppression 7 (4.7) 82 (5.6) 0.64
Cause for ICU admission:
Cardiac arrest/failure 18 (12.1) 117 (8) 0.08
Haemorrhage 9 (6) 133 (9.1) 0.21
Operative intervention 32 (21.5) 446 (30.5) 0.02
Respiratory failure 38 (25.5) 230 (15.6) <0.01
Sepsis 23 (15.4) 202 (13.8) 0.6
Trauma 7 (4.7) 70 (4.8) 0.96
Neurological failure 5 (3.4) 108 (7.4) 0.07
Other 17 (11.4) 154 (10.5) 0.75
Recorded data in the first 24 hours after ICU referral:
Intubated 98 (66) 847 (58) 0.07
Lowest PaO2:FiO2 (kPa) 25.8 (± 15.1) 29.6 (± 18) 0.02
Mean arterial pressure (mmHg) 80.2 (± 33.1) 79.1 (± 32.3) 0.71
Creatinine (μmol/l) 91 (73.2 to 143) 94 (72 to 147) 0.69
Lowest bicarbonate (mmol/l) 19.4 (± 4.4) 19.6 (± 8.1) 0.72
GCS 6 (3 to 15) 10 (3 to 15) 0.03
Bilirubin (μmol/l) 22.7 (± 31.9) 20.3 (± 31) 0.41
Haemoglobin (g/l) 11.2 (± 2.1) 11.4 (± 1.9) 0.2
Data shown as N (%), mean (± SD) or median (IQR)
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quartile of delay, >10 hours). There was no difference in
the length of ICU stay in the longest delayed admissions
compared to no-delay patients (median 5.2 vs. 4.6 days
respectively, P = 0.61) or compared to those whose delay
was in the lowest (<4.5 hours) quartile (median 5.2 days -
highest quartile vs. 5.1 days - lowest quartile, P = 0.79).
Similarly, the ICU mortality rate was not increased at
20.1% (7/34), in the longest delayed patients.
The majority of patients (73.8%) in the delayed admis-
sion group were managed in the operating theatre suite
pending ICU admission. There was no difference in
length of ICU stay between those managed in the theatre
suite compared to those managed in the ED/wards dur-
ing the delay period (median 4.8 vs. 5.8 days respectively,
P = 0.36). However, there was a trend toward a higher
ICU mortality in patients not managed within the theatre
suite during the delay (ED/wards 38.5% mortality (15/39)
vs. theatre suite 22.7% mortality (25/110), P = 0.06) that
persisted after adjusting for baseline characteristics (OR
2.94, 95% CI 0.89 to 6.46, P = 0.08).
There was a trend toward patients in the delay group
having higher rates of intubation during the first 24 hours
after ICU referral (66% delayed vs. 58% non-delayed, P =
0.07, Table 2) and the delay group patients were more
likely to receive advanced respiratory support at some
point during their admission (92.3% delay vs. 76.4% no-
delay, P <0.01, Table 5). The delay group then required
this advanced respiratory support for significantly longer
than those in the no-delay group (median 4 vs. 3 days
respectively, P = 0.04). There were no significant differ-
ences in the requirements for basic respiratory and cardio-
vascular support, advanced cardiovascular support, or
renal support between the groups (Table 5).
Discussion
In this study we did not find an increased length of ICU
stay, ICU mortality or hospital mortality rate in those
patients whose admission to intensive care was delayed
more than three hours. However, patients whose ICU
admission was delayed had both a greater requirement
for, and spent more time receiving, advanced respiratory
support, that is, invasive mechanical ventilation.
The idea of a “golden hour” after major trauma, during
which interventions made promptly after the initial injury
carry the highest chance of preventing death, has been in
use since the 1970’s [17]. Although some controversy
remains about its evidence base the concept has become
well established [18]. Recent studies in critically ill
patients who have sepsis have demonstrated that the
early recognition of pathology and implementation of
therapies, such as fluid resuscitation and appropriate
antibiotics, can reduce mortality [19,20]. Such accelerated
treatments now represent the accepted gold standard for
a variety of conditions, such as myocardial infarction and
stroke [21,22]. These studies suggest that time to treat-
ment has a profound effect on outcome.
Whilst ICU admission can be seen as a surrogate for
time to treatment in the critically ill, the fundamental
factors determining outcome are likely to include specific
interventions and the timely instigation of organ support.
These do not always mandate immediate ICU admission
and can be instigated on alternate sites, such as the ED
or operating theatre suite, whilst an ICU bed is made
Figure 2 Length of ICU stay. Components: Black line = median;
Box margins = 25th and 75th percentile; Whiskers = x1.5 of inter-
quartile range (IQR); Circles = outliers (> × 1.5 of IQR).
Table 3 Linear regression analysis
Covariates b (slope) 95% CI of b P-value
Age 0.04 0.03 to 0.07 0.03
APACHE II 0.06 -0.02 to 0.13 0.12
Male sex 1.28 0.09 to 2.46 0.04
Respiratory failure 1.48 -1.42 to 3.1 0.07
Operative intervention 1.5 0.13 to 2.87 0.03
Delayed admission 0.48 -1.5 to 2.46 0.64
Linear regression analysis: dependent variable is length of ICU stay in days.
For continuous variables (age and APACHE II score) b refers to incremental
increase in age/score.
Table 4 Binary regression analysis
Covariates Odds ratio 95% CI P-value
Age 0.995 0.99 to 1.0 0.22
APACHE II 1.15 1.13 to 1.17 <0.001
Male sex 0.91 0.68 to 1.21 0.5
Respiratory failure 1.03 0.65 to 1.46 0.9
Operative intervention 1.24 0.87 to 1.75 0.23
Delayed admission 1.27 0.81 to 2.00 0.29
Binary logistic regression analysis: dependent variable is ICU mortality.
For continuous variables (age and APACHE II score) OR refers to incremental
increase in age/score.
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available. This concept of “critical care without walls” is
increasingly becoming accepted [23] and is in place at
Charing Cross Hospital where the theatre suite is used to
“board” patients pending ICU admission. Here patients
are managed with ICU specialist input and it is feasible
for all required treatments and interventions to be insti-
gated. This practice may go some way to explaining why,
in our study, delayed ICU admission did not prolong ICU
admission or adversely effect mortality. Indeed, it is this
practice of boarding that explains the large percentage of
patients in the delay group admitted from the theatre
suite as the patients are generally transferred and mana-
ged here whilst an ICU bed is created. This accounts for
both the high percentage of delay admissions from thea-
tres and their paradoxically low rates of surgery. Interest-
ingly, the patients managed within the theatre suite had a
trend towards a lower mortality compared to those
patients managed in the ED/wards during the delay per-
iod. This suggests that the practice of boarding a patient
in the theatre suite may be a better strategy than keeping
the patients in situ on the ward if an ICU bed is not
immediately available.
The incidence of delayed admission to the ICU in our
study was 9.3%. Although there were no significant dif-
ferences in demographics between the two groups, there
was a trend toward a younger age within the delay
group that may have had an effect on the outcome data.
There were also baseline differences between the groups,
with the delay group having significantly more patients
with respiratory failure and fewer patients undergoing
surgery immediately prior to admission. However,
adjusting for these differences in linear and logistic
regression analysis models did not alter the results.
Previous studies have described an association between
prolonged hospital stay prior to ICU admission and
increased mortality rates [24]. Other studies have
described a high mortality amongst those ICU survivors
discharged to the general ward at night [25], but few stu-
dies have examined the effect of a delay in ICU admission
upon patient outcome. A North American study [26]
examined 50,322 ICU transfers from the emergency
department and defined a delayed admission as taking
longer than six hours. Amongst the delayed group there
was a significantly prolonged length of hospital stay, as
well as increased ICU and hospital mortality. Subse-
quently, a European study [27] compared patients with
community-acquired pneumonia admitted directly from
the emergency department (no-delay) to the ICU, with
patients admitted first to the general ward (delay). After
adjusting for propensity score, an increased 28-day and
hospital mortality were found in the delay group.
Recently, a Brazilian study examined 401 ICU admissions
and reported delay rates of 68.8% with a median duration
of 17.8 hours [28]. These were associated with an
increased length of ICU stay and mortality, with each
hour of delay associated with a 1.5% increase in risk of
ICU death. The high delay rate that they report is
explained by their strict inclusion criteria (any patient
not admitted immediately); however, the average delay
was markedly longer in the Brazilian study (17.8 hours)
compared to the 6 hours in our study. This may explain
why, even after adjusting for baseline characteristics in a
multivariate analysis, we found no association between
length of delay and length of ICU stay or mortality.
Differences between our results and those of previous
studies may also reflect differences in the management
Table 5 Organ support data
DelayN = 52 No-DelayN = 546 P-value
Advanced respiratory support days
N receiving (%) 48 (92.3) 417 (76.4) <0.01
median (IQR) 4 (2 to 9) 3 (2 to 7) 0.04
Basic respiratory support days
N receiving (%) 31 (59.6) 341 (62.4) 0.67
median (IQR) 2 (1 to 3.3) 2 (1 to 4) 0.98
Advanced CV support days
N receiving (%) 23 (44.2) 252 (46.3) 0.89
median (IQR) 4 (2 to 8) 3 (2 to 6) 0.28
Basic CV support days
N receiving (%) 47 (90.4) 472 (86.4) 0.42
median (IQR) 4 (2 to 8) 4 (2 to 7) 0.90
Renal support days
N receiving (%) 7 (13.4) 99 (18.1) 0.39
median (IQR) 2 (2 to 6) 4 (2 to 12) 0.42
Only patients with critical care data set (n = 598) are included in analysis. Those not fulfilling the criteria for an organ support category (Table 1) were excluded
from the analysis of duration of support for that system.
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of these patients whilst an ICU bed is awaited. Within
our institution two anaesthetic trainees manage these
patients with senior input from the ICU specialist. Care
directed by, or involving mandatory consultation from,
an ICU specialist has been shown to improve outcomes
[29], but may not be employed across all institutions
and countries. A North American study reporting
increased mortality associated with delayed in-patient
transfer to an “open” ICU, in which all physicians had
admitting rights, noted that delayed patients were less
likely to have received a prompt physician review with-
out specifying whether this was by an ICU specialist
[30]. Another study reported that patients refused ICU
admission due to lack of bed availability had a higher
mortality if they were subsequently admitted to ICU but
did not report how they were managed in the interim
[31].
We found that delayed patients had a greater require-
ment for and duration of advanced respiratory support.
This is likely to be due to the high rates of respiratory
failure as the reason for ICU admission. Patients who
require mechanical ventilation may be over-represented
in the delay group as there is no facility to provide venti-
lation on the general ward, hence they would be trans-
ferred to ICU or the theatre suite immediately. This is
not the case with other organ support strategies (for
example, inotropes), which may sometimes be delivered
on the general ward if an ICU bed is not available. This
has important implications for clinical practice given that
the delay group patients had a worse PaO2:FiO2 ratio
during the first 24 hours after ICU referral compared to
the no-delay group. Often these patients will receive
mechanical ventilatory support from a portable transfer
ventilator and/or an anaesthetic machine during the
delay period and this may be detrimental to their respira-
tory physiology. It can be more difficult to provide lung
protective ventilation (limiting pressure and volume, and
providing positive end expiratory pressure) using these
simple ventilators compared to a modern ICU ventilator.
It has now become common practice within our hospital
to manage patients with severe respiratory pathology
waiting in the operating theatre suite by using an ICU
ventilator whenever possible.
Limitations of our study must be considered. First, it
was a retrospective analysis and organ support data were
only collected for the final 21 months of the five-year
period. However, ICU outcome data were available for all
patients and hospital outcome data were only missing for
<1% of patients. Although 1,609 patients were included
over a five-year period, only 149 patients had a delayed
admission and thus the power of the study is limited. In
particular, it should be noted that the upper 95% confi-
dence interval for ICU mortality in the delayed admission
group is 2.0 and, therefore, we cannot exclude a potential
doubling of mortality rates based on these data alone. It
is possible that a larger patient cohort, with a larger num-
ber of delayed patients might detect significant differ-
ences in outcomes between delayed and non-delayed
admissions. Using the data from this study, a power cal-
culation suggests that approximately 25,000 patients
would need to be studied to have 80% power to demon-
strate a statistically significant difference in mortality
rates. Clearly this would require a national multi-centre
study and although it would have more power, any differ-
ence in outcome might also be affected by different
management policies while a patient waited for ICU
admission.
Conclusions
In this study, managing critically ill patients “in-house”
in a monitored environment when an ICU bed is una-
vailable is a viable option and did not prolong ICU stay
or result in increased mortality. However, delayed ICU
admission was associated with increased rates and a
longer duration of mechanical ventilation and, therefore,
robust strategies to provide lung protective ventilation
need to be in place.
Key messages
• Delayed ICU admission due to bed unavailability is
common.
• Managing patients in the theatre suite whilst an ICU
bed is arranged is a viable option.
• Patients whose ICU admission is delayed have
increased rates and a longer duration of invasive
mechanical ventilation.
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